行情

MTP

MTP

Midatech Pharma
NASDAQ

实时行情|Nasdaq Last Sale

1.280
-0.050
-3.76%
交易中 09:48 09/23 EDT
开盘
1.280
昨收
1.330
最高
1.282
最低
1.210
成交量
8.78万
成交额
--
52周最高
10.90
52周最低
1.031
市值
--
市盈率(TTM)
-0.6007
分时
5日
1月
3月
1年
5年

MTP 新闻

  • 韩9月前20天出口大减21.8% 预计将连续第10月下滑
  • 新浪财经综合.7小时前
  • 韩贸易协会:中国移动支付利用率是韩国2.7倍
  • 新浪财经综合.7小时前
  • 外媒:英美领导人同意2020年7月前达贸易协议
  • 中国新闻网.7小时前
  • WeWork公司董事会欲解除CEO职务 获软银支持
  • 界面.8小时前

更多

所属板块

生物技术和医学研究
+0.06%
制药与医学研究
+0.05%

热门股票

名称
价格
涨跌幅

MTP 简况

Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company's segments include Pipeline Research and Development, and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Commercial segment distributes and sells the commercial products. Its products include Zuplenz, Gelclair, Oravig and Soltamox. Zuplenz is an oral soluble film indicated for moderately emetogenic chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV). Gelclair is a product indicated for the management and relief of pain due to oral mucositis. Oravig is an orally dissolving buccal tablet approved for oral thrush. Soltamox is an oral liquid solution of tamoxifen citrate for the prevention of breast cancer.
展开

Webull提供Midatech Pharma PLC-ADR的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。